Cargando…
Local treatment with the selective IκB kinase β inhibitor NEMO-binding domain peptide ameliorates synovial inflammation
Nuclear factor (NF)-κB is a key regulator of synovial inflammation. We investigated the effect of local NF-κB inhibition in rat adjuvant arthritis (AA), using the specific IκB kinase (IKK)-β blocking NF-κB essential modulator-binding domain (NBD) peptide. The effects of the NBD peptide on human fibr...
Autores principales: | Tas, Sander W, Vervoordeldonk, Margriet J, Hajji, Najat, May, Michael J, Ghosh, Sankar, Tak, Paul P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1779420/ https://www.ncbi.nlm.nih.gov/pubmed/16684367 http://dx.doi.org/10.1186/ar1958 |
Ejemplares similares
-
The effects of NF-κB inhibition by a NEMO binding domain peptide in vitro and in vivo
por: Tas, SW, et al.
Publicado: (2004) -
Differential effects of T-cell specific PKC-theta inhibition or selective intra-articular NF-κB inhibition on synovial inflammation in rat adjuvant arthritis
por: Tas, SW, et al.
Publicado: (2005) -
Intra-articular gene therapy blocking NF-κB using adeno-associated virus type 5 ameliorates adjuvant arthritis in rats
por: Adriaansen, J, et al.
Publicado: (2005) -
Gene Therapy Targeting Nuclear Factor-κB: Towards Clinical Application in Inflammatory Diseases and Cancer
por: Tas, Sander W., et al.
Publicado: (2009) -
Disulfide-Mediated Stabilization of the IκB
Kinase Binding Domain of NF-κB Essential Modulator (NEMO)
por: Zhou, Li, et al.
Publicado: (2014)